Scienture Holdings, Inc.

SCNX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Assets
Cash & Equivalents $6.7M — $151.9K $1.1M $3.1M $5.9M $2.9M $869.6K
Accounts Receivable $731.3K $11.1K $821.8K $629.9K $979.0K $805.0K $792.1K $433.6K
Inventory $213.4K — $968 $65.5K $56.3K $1.3M $56.8K $80.0K
Total Current Assets $7.9M $6.3M $2.8M $2.1M $4.4M $9.2M $3.8M $1.5M
Property, Plant & Equipment $15.5K $17.5K $7.5K $65.2K $98.8K $162.4K $175.0K $15.0K
Goodwill — $21.4M — $0 $0 — $726.0K $726.0K
Intangible Assets (Excl. Goodwill) $71.0M $76.4M $9.0M $792.0K — — — —
Total Assets $84.2M $104.9M $12.5M $3.7M $5.8M $9.8M $5.6M $2.2M
Liabilities
Accounts Payable $1.4M $2.9M $1.5M $528.0K $477.0K $256.8K $334.6K $400.5K
Total Current Liabilities $2.7M $7.9M $11.6M $2.1M $926.0K $842.2K $520.8K $860.4K
Long-Term Debt — $2.9M — — — — $225.0K $522.1K
Total Liabilities $14.1M $25.8M $12.0M $3.4M $2.0M $1.1M $1.4M $1.4M
Stockholders' Equity
Retained Earnings $-80.6M $-39.0M $-33.2M $-19.7M $-16.2M $-10.9M $-8.4M $-8.1M
Total Stockholders' Equity $70.1M $79.1M $542.4K $763.1K $3.8M $8.7M $4.1M $844.7K
← Newer Page 1 of 2 Older →